Some of today's most popular products are the same things our grandparents bought decades ago. Bayer aspirin, Ivory soap, and ...

Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s ... s visual identity, the logo for the independent new ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price target of $185.00. The company’s shares closed last ...

That said, one stock that continues to stand out is Johnson & Johnson JNJ. The pharmaceutical giant's stock hit new 52-week highs of nearly $170 on Tuesday, with JNJ now up +16% year to date.

In a report released yesterday, Shagun Singh Chadha from RBC Capital initiated coverage with a Buy rating on Johnson & Johnson (JNJ – Research Report) and a price target of $181.00. The company ...

Meta has ditched the pink/purple hued design it introduced in 2020 and replaced it with a more boring version. The new design ...

Johnson & Johnson (NYSE:JNJ) has decided to resume a limited market rollout of its heart rhythm device Varipulse after an investigation indicated no safety concerns, the MedTech giant announced.

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Investor model based on the published ...

Ford has used some version of its famous script logo for more than a century, but despite its widespread usage, people are scratching their heads over a detail they just noticed. In a viral TikTok ...

Johnson & Johnson recently announced the appointment of Jessica Moore as the Group Chief Financial Officer for their Innovative Medicine division, a step reflecting the company’s focus on robust ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street ...

After I have presented the key tasks I faced when creating "ALLKA 4D Rating", I will move on to comparing Johnson & Johnson and Pfizer and choose the winner in the category "the most promising ...